Cargando…
A conjugate of an anti-midkine single-chain variable fragment to doxorubicin inhibits tumor growth
Doxorubicin (DOX) was conjugated to a single-chain variable fragment (scFv) against human midkine (MK), and the conjugate (scFv-DOX) was used to target the chemotherapeutic agent to a mouse solid tumor model in which the tumor cells expressed high levels of human MK. The His-tagged recombinant scFv...
Autores principales: | Zhao, Shuli, Zhao, Guangfeng, Xie, Hao, Huang, Yahong, Hou, Yayi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Medicina Tropical
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854202/ https://www.ncbi.nlm.nih.gov/pubmed/22267001 http://dx.doi.org/10.1590/S0100-879X2012007500009 |
Ejemplares similares
-
Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells
por: Zhang, Dongya, et al.
Publicado: (2017) -
Midkine in Inflammation
por: Weckbach, Ludwig T., et al.
Publicado: (2011) -
A Human Anti-c-Met Fab Fragment Conjugated with Doxorubicin as Targeted Chemotherapy for Hepatocellular Carcinoma
por: Chen, Ximin, et al.
Publicado: (2013) -
Midkine’s Role in Cardiac Pathology
por: Woulfe, Kathleen C., et al.
Publicado: (2017) -
Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer
por: Toyoda, Eiji, et al.
Publicado: (2008)